Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Dec;27(12):4461-4467.
doi: 10.1007/s00520-019-04745-w. Epub 2019 Mar 22.

Mood outcomes of a behavioral treatment for urinary incontinence in prostate cancer survivors

Amy Y Zhang  1 , Stephen Ganocy  2 , Alex Z Fu  3 , Denise Kresevic  4 , Lee Ponsky  5 , Gerald Strauss  4 , Donald R Bodner  4   5 , Hui Zhu  4
Affiliations
Randomized Controlled Trial

Mood outcomes of a behavioral treatment for urinary incontinence in prostate cancer survivors

Amy Y Zhang et al. Support Care Cancer. 2019 Dec.

Abstract

Purpose: This study aimed to assess whether prostate cancer survivors who received a behavioral intervention to urinary incontinence had experienced a significant mood improvement.

Methods: One hundred fifty-three prostate cancer survivors with persistent incontinence were included in this secondary data analysis. They were randomly assigned to usual care or interventions that provided pelvic floor muscle exercises and self-management skills. All subjects had measures of anxiety, depression, and anger at baseline, 3 months (post-intervention), and 6 months (follow-up). Negative binomial regression analysis was performed to examine the group status, daily leakage frequency at 3 months, and their interactions at 3 months as predictors for mood outcomes at 6 months, controlling for demographic and medical variables.

Results: The main effect of daily leakage frequency at 3 months significantly predicted anxiety at 6 months (p < .01). The group main effect on any mood outcomes at 6 months was not statistically significant. The interaction between the group and 3-month leakage had a significant effect on anxiety; intervention subjects achieving a significant leakage reduction at 3 months exhibited significantly less anxiety at 6 months than other subjects (p = .04). Age, employment status, and receiving surgery at baseline were significantly associated with less anxiety, depression, and anger at 6 months.

Conclusions: Reduced urinary incontinence significantly predicted less anxiety, especially among the intervention subjects. The findings suggest a significant association between a behavioral therapy of urinary incontinence and anxiety reduction in prostate cancer survivors.

Keywords: Anxiety; Behavioral intervention; Cancer care; Prostate cancer; Psychosocial studies.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest The authors declare that they do not have a financial relation with the funding agency NIH except for honoraria received when performing grant reviews. The authors have full control of the primary data that is available for the journal’s review if requested.

Ethical compliance Informed consent was obtained from all individual participants included in the study. This study has not been published and is not under consideration for publication elsewhere. All authors have contributed to this article through research participation, data collection or data analysis, and manuscript production. They provided financial disclosure under the Conflict of Interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kollberg KS, Wilderäng U, Thorsteinsdottir T, Hugosson J, Wiklund P, Bjartell A, Carlsson S, Stranne J, Haglind E, Steineck G (2017) How badly did it hit? Self-assessed emotional shock upon prostate cancer diagnosis and psychological well-being: a follow-up at 3, 12, and 24 months after surgery. Acta Oncol 56:984–990 - PubMed
    1. Lane A, Metcalfe C, Young GJ, Peters TJ, Blazeby J, Avery KN, Dedman D, Down L, Mason MD, Neal DE, Hamdy FC, Donovan JL, ProtecT Study group (2016) Patient-reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and quality of life. BJU Int 118(6):869–879 - PMC - PubMed
    1. Korfage IJ, Essink-Bot ML, Janssens ACJW, Schröder FH, de Koning HJ (2006) Anxiety and depression after prostate cancer diagnosis and treatment: 5-year follow-up. Br J Cancer 94:1093–1098 - PMC - PubMed
    1. Sharp L, O’Leary E, Kinnear H, Gavin A, Drummond FJ (2016) Cancer-related symptoms predict psychological wellbeing among prostate cancer survivors: results from the PiCTure study. Psycho-Oncology 25:282–291 - PubMed
    1. Watson E, Shinkins B, Frith E, Neal D, Hamdy F, Walter F, Weller D, Wilkinson C, Faithfull S, Wolstenholme J, Sooriakumaran P, Kastner C, Campbell C, Neal R, Butcher H, Matthews M, Perera R, Rose P (2016) Symptoms, unmet needs, psychological wellbeing and health status in survivors of prostate cancer: implications for redesigning follow-up. BJU Int 117:E10–E19 - PubMed

Publication types